Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL729 (A-157378-0, A-157378.0, ABT-378, Aluviran, Kaletra, Koletra, Lopinavir, Lopinavir-, Lopinavir, (s-(2s,4s,5s))-, Lopinavirum) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
ChEMBL | Inhibition of human ABCG2 expressed in dog MDCK-II-BCRP cells mediated pheophorbide A efflux preincubated with PhA followed by compound addition and measured after 60 mins by flow cytometry | B | 5.12 | pIC50 | 7600 | nM | IC50 | Eur J Med Chem (2022) 237: 114346-114346 [PMID:35483322] |
CAAX prenyl protease 1 homolog in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075286] [UniProtKB: Q80W54] | ||||||||
ChEMBL | Inhibition of mouse ZMPSTE24 expressed n delta ste24 delta rce1 yeast | B | 4.74 | pIC50 | 18400 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 13432-13437 [PMID:17652517] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 5.07 | pIC50 | 8511.38 | nM | IC50 | Eur J Med Chem (2011) 46: 618-630 [PMID:21185626] |
Human immunodeficiency virus type 1 protease in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL243] [UniProtKB: Q72874] | ||||||||
ChEMBL | Binding affinity for human immunodeficiency virus type 1 protease | B | 10 | pKd | 0.1 | nM | Kd | J Med Chem (2004) 47: 5953-5961 [PMID:15537350] |
ChEMBL | Inhibition of HIV1 protease L10I/G48V/I54V/L63P/V82A mutant | B | 8.21 | pKi | 6.1 | nM | Ki | J Med Chem (2006) 49: 7342-7356 [PMID:17149864] |
ChEMBL | Inhibition of HIV1 recombinant protease V32I/I47A mutant expressed in Escherichia coli by spectrophotometric assay | B | 8.62 | pKi | 2.4 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 protease L10I/L63P/A71V/G73S/I84V/L90M mutant | B | 9.05 | pKi | 0.9 | nM | Ki | J Med Chem (2006) 49: 7342-7356 [PMID:17149864] |
ChEMBL | Inhibition of HIV1 recombinant protease L10F/L19I/K20R/L33F/E35D/M36I/R41K/F53L/I54V/L63P/H69K/A71V/T74P/I84V/L89M/L90M/I93L mutant expressed in Escherichia coli by spectrophotometric assay | B | 9.3 | pKi | 0.5 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 recombinant protease L10I/L24I/L33F/M46L/I54V/L63P/A71V/V82A/I84V mutant expressed in Escherichia coli by spectrophotometric assay | B | 9.36 | pKi | 0.44 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition constant for human immunodeficiency virus type 1 protease | B | 10.1 | pKi | 0.08 | nM | Ki | J Med Chem (2004) 47: 5953-5961 [PMID:15537350] |
ChEMBL | Inhibition of HIV1 recombinant protease A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay | B | 10.22 | pKi | 0.06 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 protease D30N/L63P/N88D mutant | B | 10.4 | pKi | 0.04 | nM | Ki | J Med Chem (2006) 49: 7342-7356 [PMID:17149864] |
ChEMBL | Inhibition of HIV1 recombinant protease M46I/A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay | B | 10.54 | pKi | 0.03 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay | B | 10.54 | pKi | 0.03 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 recombinant protease D30N/N88D mutant expressed in Escherichia coli by spectrophotometric assay | B | 10.59 | pKi | 0.03 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 subtype C protease Q7K mutant expressed in Escherichia coli BL21 (DE3) pLysS using Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 as substrate by spectrophotometry | B | 7.6 | pIC50 | 25 | nM | IC50 | Eur J Med Chem (2011) 46: 3976-3985 [PMID:21741133] |
ABCB1/P-glycoprotein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4302] [GtoPdb: 768] [UniProtKB: P08183] | ||||||||
ChEMBL | Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells | B | 4.99 | pIC50 | 10300 | nM | IC50 | Antimicrob Agents Chemother (2007) 51: 3498-3504 [PMID:17664327] |
ChEMBL | TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in Caco-2 cells | F | 5.77 | pIC50 | 1700 | nM | IC50 | AIDS (2003) 17: 1092-1094 [PMID:12700464] |
Plasmodium falciparum plasmepsin V/Plasmepsin V in Plasmodium falciparum 3D7 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3559649] [GtoPdb: 3106] [UniProtKB: Q8I6Z5] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum DC6 plasmepsin-5 using DABCYL-GNKRTLAQKQG-EDANS as substrate measured every 15 mins of 75 mins by fluorescence assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | ACS Med Chem Lett (2014) 5: 89-93 [PMID:24900778] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimalarial activity against Plasmodium falciparum W2 by [3H]hypoxanthine uptake | F | 5.57 | pIC50 | 2700 | nM | IC50 | Eur J Med Chem (2009) 44: 3816-3820 [PMID:19403210] |
ChEMBL | DNDI: Malaria in Vitro, 72 hour | F | 5.72 | pIC50 | 1920 | nM | IC50 | Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning |
ChEMBL | Antimicrobial activity against Plasmodium falciparum harboring HFP-tagged Pfs16 protein after 48 hrs | F | 5.52 | pEC50 | 3000 | nM | EC50 | Antimicrob Agents Chemother (2010) 54: 1334-1337 [PMID:20028821] |
ChEMBL | Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs | F | 5.7 | pEC50 | 2000 | nM | EC50 | Antimicrob Agents Chemother (2010) 54: 1334-1337 [PMID:20028821] |
ChEMBL | Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs | F | 5.7 | pEC50 | 2000 | nM | EC50 | Antimicrob Agents Chemother (2010) 54: 1334-1337 [PMID:20028821] |
Protease in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2366517] [UniProtKB: Q9YQ12] | ||||||||
ChEMBL | Binding affinity to HIV1 protease I47A mutant | B | 8.96 | pKd | 1.1 | nM | Kd | J Med Chem (2016) 59: 4171-4188 [PMID:26356253] |
ChEMBL | Inhibition of HIV1 protease expressed in Escherichia coli by fluorometric assay | B | 8.85 | pKi | 1.4 | nM | Ki | J Med Chem (2010) 53: 607-615 [PMID:19961222] |
ChEMBL | Inhibition of HIV1 NL4-3 protease I50V/A71V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing protease cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay | B | 10.21 | pKi | 0.06 | nM | Ki | J Med Chem (2020) 63: 8296-8313 [PMID:32672965] |
ChEMBL | Inhibition of HIV1 NL4-3 protease I84V mutant expressed in Escherichia coli TAP-106 cells using EDANS/DABCYL-labelled 10-amino acid containing protease cleavage site as substrate preincubated for 1 hr followed by substrate addition and measured for 60 mins by FRET assay | B | 10.29 | pKi | 0.05 | nM | Ki | J Med Chem (2020) 63: 8296-8313 [PMID:32672965] |
ChEMBL | Inhibition of HIV1 protease using fluorogenic hexapeptide substrate (2-aminobenzoyl)Thr-Ile-Nle-(p-nitro)Phe-Gln-Arg by fluorimeter | B | 10.43 | pKi | 0.04 | nM | Ki | Medchemcomm (2011) 2: 1093-1098 |
ChEMBL | Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay | B | 10.74 | pKi | 0.02 | nM | Ki | J Med Chem (2008) 51: 4839-4843 [PMID:18598016] |
ChEMBL | Inhibition of HIV1 protease | B | 10.8 | pKi | 0.02 | nM | Ki | Bioorg Med Chem (2008) 16: 1299-1308 [PMID:17981045] |
ChEMBL | Inhibition of HIV1 protease | B | 10.85 | pKi | 0.01 | nM | Ki | Antimicrob Agents Chemother (2007) 51: 4036-4043 [PMID:17638694] |
ChEMBL | Inhibition of HIV1 subtype C protease expressed in Escherichia coli BL21 assessed as hydrolysis of substrate using chromogenic substrate Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 by spectrophotometric analysis | B | 7.6 | pIC50 | 25 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 2274-2277 [PMID:21429747] |
ChEMBL | Inhibition of South African HIV1 subtype C protease expressed in Escherichia coli BL21S4 (DE3)pLysS cells using Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 as substrate by spectrophotometry | B | 7.6 | pIC50 | 25 | nM | IC50 | Eur J Med Chem (2012) 53: 13-21 [PMID:22542107] |
ChEMBL | Inhibition of wild type C-South African Human immunodeficiency virus 1 protease using chromogenic peptide H-1048 as substrate by UV spectrophotometric analysis | B | 7.6 | pIC50 | 25 | nM | IC50 | Med Chem Res (2013) 22: 3918-3933 |
ChEMBL | Inhibition of HIV-1 NL4-3 wild type protease expressed in Escherichia coli preincubated for 20 mins by FRET analysis | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Bioorg Med Chem (2013) 21: 7430-7434 [PMID:24128815] |
ChEMBL | Inhibition of protease L10F/V32I/M46I/I47V/Q58E/I84V mutant in HIV1 A17 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay | B | 5.94 | pEC50 | 1160 | nM | EC50 | J Med Chem (2018) 61: 5138-5153 [PMID:29852069] |
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
ChEMBL | Inhibition of SARS-CoV-2 MPro | B | 4.7 | pIC50 | >20000 | nM | IC50 | Bioorg Med Chem (2021) 29: 115860-115860 [PMID:33191083] |
ChEMBL | Inhibition of SARS-CoV-2 main protease | B | 5.04 | pIC50 | 9120 | nM | IC50 | Eur J Med Chem (2020) 201: 112559-112559 [PMID:32563814] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]